Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laith J Abu-Raddad

Showing results (281-290 of 318) with videos related to

Pageof 32
Sort By:
Plos Medicine|December 16, 2021
Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort studyLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
Open Forum Infectious Diseases|March 17, 2025
Evaluating Hospital Admission Data as Indicators of COVID-19 Severity: A National Assessment in QatarLayan Sukik, Hiam Chemaitelly, Houssein H Ayoub, et al.
BMJ Open Respiratory Research|March 26, 2025
Protection conferred by SARS-CoV-2 infection across a spectrum of reinfection symptoms and severitiesLayan Sukik, Hiam Chemaitelly, Houssein H Ayoub, et al.
The New England Journal of Medicine|June 15, 2022
Effects of Previous Infection and Vaccination on Symptomatic Omicron InfectionsHeba N Altarawneh, Hiam Chemaitelly, Houssein H Ayoub, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2021
Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta VariantLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
The New England Journal of Medicine|March 9, 2022
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in QatarLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
BMJ Public Health|February 28, 2025
Turning point in COVID-19 severity and fatality during the pandemic: a national cohort study in QatarHiam Chemaitelly, Houssein H Ayoub, Jeremy Samuel Faust, et al.
Frontiers in Immunology|September 30, 2022
Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infectionsSuelen H Qassim, Mohammad R Hasan, Patrick Tang, et al.
Journal of Travel Medicine|September 30, 2022
Duration of immune protection of SARS-CoV-2 natural infection against reinfectionHiam Chemaitelly, Nico Nagelkerke, Houssein H Ayoub, et al.
The New England Journal of Medicine|November 2, 2022
Covid-19 Vaccine Protection among Children and Adolescents in QatarHiam Chemaitelly, Sawsan AlMukdad, Houssein H Ayoub, et al.
Pageof 32

Showing results (281-290 of 318) with videos related to

Sort By:
Pageof 32
Plos Medicine|December 16, 2021
Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort studyLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
Open Forum Infectious Diseases|March 17, 2025
Evaluating Hospital Admission Data as Indicators of COVID-19 Severity: A National Assessment in QatarLayan Sukik, Hiam Chemaitelly, Houssein H Ayoub, et al.
BMJ Open Respiratory Research|March 26, 2025
Protection conferred by SARS-CoV-2 infection across a spectrum of reinfection symptoms and severitiesLayan Sukik, Hiam Chemaitelly, Houssein H Ayoub, et al.
The New England Journal of Medicine|June 15, 2022
Effects of Previous Infection and Vaccination on Symptomatic Omicron InfectionsHeba N Altarawneh, Hiam Chemaitelly, Houssein H Ayoub, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2021
Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta VariantLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
The New England Journal of Medicine|March 9, 2022
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in QatarLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
BMJ Public Health|February 28, 2025
Turning point in COVID-19 severity and fatality during the pandemic: a national cohort study in QatarHiam Chemaitelly, Houssein H Ayoub, Jeremy Samuel Faust, et al.
Frontiers in Immunology|September 30, 2022
Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infectionsSuelen H Qassim, Mohammad R Hasan, Patrick Tang, et al.
Journal of Travel Medicine|September 30, 2022
Duration of immune protection of SARS-CoV-2 natural infection against reinfectionHiam Chemaitelly, Nico Nagelkerke, Houssein H Ayoub, et al.
The New England Journal of Medicine|November 2, 2022
Covid-19 Vaccine Protection among Children and Adolescents in QatarHiam Chemaitelly, Sawsan AlMukdad, Houssein H Ayoub, et al.
Pageof 32